Index
S&P 500
Market Cap
29.32B
Enterprise Value
29.20B
Income
564.90M
Sales
3.33B
Book/sh
42.47
Cash/sh
6.19
Employees
10800
IPO
Mar 17, 1980
P/E
53.27
Forward P/E
41.54
PEG
2.58
P/S
8.81
P/B
9.81
P/C
67.29
P/FCF
67.12
EV/EBITDA
32.01
EV/Sales
8.78
Quick Ratio
2.12
Current Ratio
2.82
Debt/Eq
0.11
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
7.82
EPS next Y
10.03
EPS next Q
2.28
EPS this Y
23.60%
EPS next Y
11.31%
EPS next 5Y
16.13%
EPS past 3/5Y
-4.22% 8.26%
Sales past 3/5Y
2.14% 7.45%
EPS Y/Y TTM
17.07%
Sales Y/Y TTM
12.42%
EPS Q/Q
18.81%
Sales Q/Q
13.86%
Insider Own
0.75%
Insider Trans
-3.54%
Inst Own
103.05%
Inst Trans
-2.04%
ROA
14.07%
ROE
19.09%
ROIC
17.20%
Gross Margin
36.82%
Oper. Margin
21.97%
Profit Margin
16.98%
SMA20
8.83%
SMA50
13.71%
SMA200
33.25%
Trades
Shs Outstand
70.40M
Shs Float
69.85M
52W High
404.98 2.89%
52W Low
223.83 86.15%
Volatility
1.77% 2.18%
ATR (14)
10.00
RSI (14)
80.77
Beta
1.16
Rel Volume
3.36
Avg Volume
557.17K
Volume
1,872,869
Perf Week
5.75%
Perf Month
12.38%
Perf Quarter
22.20%
Perf Half Y
40.01%
Perf YTD
51.44%
Perf Year
46.27%
Perf 3Y
29.84%
Perf 5Y
-3.07%
Perf 10Y
468.44%
Prev Close
403.64
Price
416.67
Change %
3.23%
Analysts 13 incl. previous ratings
Rating Distribution 13 Buy · 0 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 22, 2026 Upgrade M Morgan Stanley
Equal-Weight → Overweight $400 -4.0% Sep 09, 2026 Resumed U UBS
Buy $415 -0.4% Jul 13, 2026 Initiated B
Outperform $447 +7.3% Jun 09, 2026 Upgrade B Barclays
Equal Weight → Overweight $400 -4.0% Jun 02, 2026 Resumed W
Outperform $375 -10.0% Dec 02, 2025 Initiated M Morgan Stanley
Equal-Weight $285 -31.6% Sep 15, 2025 Initiated R
Buy $311 -25.4% Jun 24, 2025 Initiated B Barclays
Equal Weight $245 -41.2% Mar 18, 2025 Initiated E Evercore ISI
Outperform $275 -34.0% Feb 14, 2025 Upgrade D Deutsche Bank
Hold → Buy $250 -40.0% Jan 08, 2025 Initiated C Citigroup
Buy $400 -4.0% Dec 13, 2024 Initiated W
Peer Perform Dec 12, 2024 Upgrade U UBS
Neutral → Buy $350 → $390 -6.4% Feb 07, 2024 Upgrade J Jefferies
Hold → Buy $323 → $536 +28.6% Jun 16, 2023 Upgrade B BofA Securities
Neutral → Buy $390 → $405 -2.8% Apr 11, 2023 Upgrade S
Equal-Weight → Overweight $330 → $400 -4.0% Dec 14, 2022 Initiated D Deutsche Bank
Hold $250 -40.0% Nov 30, 2022 Initiated U UBS
Neutral $250 -40.0% Oct 28, 2022 Downgrade B BofA Securities
Buy → Neutral $385 → $250 -40.0% Nov 10, 2020 Initiated K KeyBanc Capital Markets
Overweight $350 -16.0%
Today 11:14AM
06:04AM
06:00AM
Oct-22-26 07:40AM
Oct-21-26 04:04PM
06:04PM
Loading…
Oct-19-26 06:04PM
Oct-08-26 06:00AM
Oct-05-26 06:00AM
Aug-26-26 04:00PM
06:48AM
Aug-25-26 04:41PM
Aug-07-26 05:55PM
Jul-23-26 03:01PM
06:07AM
06:00AM
04:00PM
Loading…
Jul-21-26 04:00PM
Jul-17-26 08:07AM
08:02AM
Jul-07-26 06:00AM
Jul-01-26 04:30PM
Jun-01-26 04:30PM
May-20-26 05:24PM
May-14-26 06:46AM
May-12-26 02:16AM
Apr-28-26 06:00AM
Apr-24-26 03:05AM
Apr-23-26 12:47PM
07:19AM
06:07AM
06:00AM
02:12AM
Loading…
02:12AM
Apr-09-26 06:00AM
Mar-31-26 11:46AM
Mar-13-26 11:55AM
Mar-10-26 01:03PM
12:06AM
Mar-09-26 05:07PM
04:30PM
Mar-05-26 06:43PM
Mar-03-26 11:40AM
Feb-27-26 06:00AM
Feb-25-26 09:50AM
Feb-24-26 02:40PM
Feb-23-26 11:24PM
09:55AM
Feb-20-26 09:30AM
08:00AM
Feb-19-26 12:37AM
Feb-17-26 04:00PM
09:45AM
Feb-15-26 12:09PM
Feb-13-26 11:40AM
07:13AM
Feb-12-26 01:07PM
09:30AM
07:10AM
07:02AM
06:11AM
06:10AM
(Associated Press Finance)
06:00AM
Feb-11-26 11:00AM
Feb-10-26 10:08PM
09:15AM
Feb-09-26 10:24AM
Feb-07-26 12:09PM
Feb-06-26 10:08PM
Feb-05-26 10:00AM
Feb-03-26 01:17PM
Jan-30-26 09:55AM
Jan-29-26 06:00AM
Jan-28-26 11:40AM
Jan-25-26 08:02AM
Jan-23-26 04:34PM
01:50PM
03:58AM
Jan-22-26 12:00PM
10:43AM
09:09AM
08:38AM
Jan-21-26 09:35AM
Jan-20-26 06:00AM
Jan-19-26 08:10AM
Jan-15-26 07:19AM
Jan-14-26 12:50PM
Jan-13-26 09:55AM
08:09AM
Jan-12-26 11:40AM
06:00AM
06:00AM
Jan-07-26 03:38PM
Jan-04-26 11:39PM
Dec-17-25 10:28AM
Dec-12-25 06:00AM
Dec-11-25 08:32AM
Dec-10-25 06:00AM
Dec-05-25 11:30AM
Dec-04-25 11:30AM
08:45AM
Dec-03-25 11:01PM
Nov-26-25 02:18PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Favorite Annette F Sr. VP & Chief HR Officer Sep 15 '26 Option Exercise 89.64 2,524 226,251 24,342 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 11 '26 Option Exercise 89.64 2,500 224,100 24,318 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 14 '26 Option Exercise 89.64 2,500 224,100 24,318 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 15 '26 Sale 365.00 2,524 921,260 21,818 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 14 '26 Sale 355.00 2,500 887,500 21,818 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 11 '26 Sale 345.00 2,500 862,500 21,818 Sep 15 04:37 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 08 '26 Option Exercise 85.37 8,135 694,453 19,663 Sep 10 05:36 PM Favorite Annette F Sr. VP & Chief HR Officer Sep 08 '26 Sale 340.81 8,135 2,772,489 16,845 Sep 10 05:36 PM Hofmann Thomas W Director May 07 '26 Proposed Sale 322.12 3,384 1,090,051 May 07 03:34 PM Favorite Annette F Sr. VP & Chief HR Officer Apr 27 '26 Option Exercise 83.47 2,817 235,135 19,645 Apr 29 12:22 PM Favorite Annette F Sr. VP & Chief HR Officer Apr 27 '26 Sale 305.20 2,817 859,753 16,828 Apr 29 12:22 PM Winters Chad VP, Chief Accounting Officer Apr 27 '26 Option Exercise 173.22 896 155,205 2,419 Apr 29 12:19 PM Winters Chad VP, Chief Accounting Officer Apr 27 '26 Sale 300.67 896 269,399 1,523 Apr 29 12:19 PM
West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions, drug delivery systems, analytical lab services, and other integrated services and solutions, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Senior VP & CFO Mr. Robert W. McMahon C.M.A.
Chief HR Officer & Senior VP Ms. Annette F. Favorite
SVP & Chief Proprietary Segment Officer Mr. Shane A. Campbell
President Mr. Michel Lagarde
VP of Finance & Chief Accounting Officer Mr. Chad R. Winters
